Multilevel tobacco intervention in community clinics for underserved families
在社区诊所为服务不足的家庭进行多层次烟草干预
基本信息
- 批准号:8885150
- 负责人:
- 金额:$ 56.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-05-01 至 2020-04-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdultAfrican AmericanAsthmaAttentionBehavior TherapyBehavioralBiologicalBiological MarkersCardiovascular DiseasesCellular PhoneCessation of lifeChildCigaretteClinicClinical Practice GuidelineCognitive TherapyCombined Modality TherapyCommunitiesControl GroupsCoping SkillsCotinineCounselingDiseaseEquilibriumEvidence based treatmentFamilyFeedbackFosteringFutureGuidelinesHome environmentImprove AccessIncomeIndividualInfantInformal Social ControlInterventionLinkLow incomeMeasuresMediatingMediator of activation proteinMinorityModelingModificationMorbidity - disease rateMothersNicotine DependenceOtitisOutcomeParentsParticipantPhiladelphiaPopulationPovertyPractice GuidelinesPregnancyPrevalencePrintingProblem behaviorPublic HealthRandomizedReportingResearchRiskScienceSelf EfficacyServicesSmokeSmokerSmokingSocial ControlsSocial supportSourceSudden infant death syndromeSymptomsSystemTelefacsimileTelephoneTestingTimeTobaccoTrainingUnderserved PopulationUrineWeightWomanWorkaddictionanxiousbasecancer riskchild bearingcravingdepressive symptomsdesigndosageenvironmental tobacco smoke exposurefollow-uphealth disparityhigh riskimprovedinnovationintervention effectmaternal cigarette smokingmobile applicationmortalitymultilevel analysisnicotine replacementnovelprimary outcomeprogramsprotective behaviorpublic health prioritiespublic health relevancequitlinesecondary outcomeself helpsmoking cessationstandard of caretheoriestherapy developmenttobacco controltooltreatment effectuptakeyoung adult
项目摘要
DESCRIPTION (provided by applicant): Children's secondhand smoke exposure (SHSe) remains a leading cause of avertible morbidity/mortality, with links to asthma, otitis, SIDS, behavior problems and risk of cancer and cardiovascular disease. Addressing SHSe is a public health priority, particularly in low-income, young children-a group with excess tobacco-related risk and burden. Community clinics (e.g., Women, Infants and Children [WIC]), can reach this population. WIC's standard practice for addressing SHSe includes minimal self-help advice to parents, an approach with inadequate efficacy. Clinical practice guidelines ("AAR") recommend that practitioners "Ask" parents about child SHSe, "Advise" them about harms, and "Refer" smokers to intensive evidence-based treatments that address multiple determinants of smoking. Thus, we propose to test a multilevel, multimodal treatment model that combines a system-level WIC intervention following AAR guidelines with a more intensive, individual-level multimodal behavioral intervention (MBI) that integrates telephone SHSe reduction and cessation counseling with coaching on NCI's QuitPal mobile app and nicotine replacement therapy (NRT) use. We will train staff in Philadelphia WIC clinics to implement AAR with auto-fax referral to the
trial. We will then randomize 372 eligible parents to receive AAR+MBI or AAR+CTL (attention control intervention). All participants will receive AAR because it is an easily adoptable, potentil standard of care in community clinics. The primary aim is to test the hypothesis that AAR+MBI compared to AAR+CTL will result in greater reductions in child cotinine (SHSe biomarker) and reported cigarettes exposed/day at 3-month end of treatment and 12-month follow-up. A secondary aim is to test the hypothesis that AAR+MBI vs. AAR+CTL will result in higher bioverified 7-day point prevalence quit rate among parents at 3- and 12-months. We will test the hypothesis that social support, urge coping skills, self-efficacy, and SHSe protective behaviors mediate effects of AAR+MBI on smoking outcomes and explore whether other residential smokers, level of nicotine dependence, depressive/anxious symptoms, weight concerns, intervention dosage, and pregnancy status moderate treatment effects. Our model balances necessary intervention intensity with feasible components (quitline, NRT, QuitPal) already available in under- served communities, thereby facilitating future dissemination. Unlike the NCI Quitline and many state services, the MBI follows best practice guidelines and does so without increasing clinic burden. It also can improve an underserved, high-risk population's access to and engagement in evidence-based treatment. This project has high impact potential: it will result in a novel, efficacious multilevel model for tackling the significant problem of child SHSe.
Secondary aims results will inform science and theory by identifying how and for whom the model works. Future dismantling research can assess orthogonal and synergistic effects of intervention components.
描述(由申请人提供):儿童的二手烟暴露(SHSe)仍然是可避免的发病率/死亡率的主要原因,与哮喘,耳炎,SIDS,行为问题以及癌症和心血管疾病的风险有关。解决SHSe是一个公共卫生优先事项,特别是在低收入,年幼的儿童,一个过度的烟草相关的风险和负担的群体。社区诊所(例如,妇女、婴儿和儿童[WIC]),可以接触到这一人群。WIC解决SHSe问题的标准做法包括向父母提供最低限度的自助建议,这种方法效果不佳。临床实践指南(“AAR”)建议从业者“询问”父母有关儿童SHSe的情况,“建议”他们有关危害,并“推荐”吸烟者接受针对吸烟的多种决定因素的强化循证治疗。因此,我们建议测试一种多层次、多模式的治疗模型,该模型将遵循AAR指南的系统级WIC干预与更密集的个体级多模式行为干预(MBI)相结合,MBI将电话SHSe减少和戒烟咨询与NCI Quittering移动的应用程序和尼古丁替代疗法(NRT)使用的指导相结合。我们将培训费城WIC诊所的工作人员实施AAR,并通过自动传真转诊至
审判然后,我们将372名合格的父母随机接受AAR+MBI或AAR+CTL(注意力控制干预)。所有参与者都将接受AAR,因为它是社区诊所中易于采用的潜在护理标准。主要目的是检验以下假设:与AAR+CTL相比,AAR+MBI将导致儿童可替宁(SHSe生物标志物)和报告的香烟暴露/天在3个月治疗结束和12个月随访时的更大降低。第二个目的是检验假设,即AAR+MBI与AAR+CTL相比,在3个月和12个月时,父母中的生物等效7天点患病率戒烟率更高。我们将检验这一假设,即社会支持,敦促应对技能,自我效能和SHSe保护行为介导AAR+MBI对吸烟结果的影响,并探讨其他住宅吸烟者,尼古丁依赖水平,抑郁/焦虑症状,体重问题,干预剂量和妊娠状态是否中度治疗效果。我们的模型平衡了必要的干预强度与服务不足社区已经提供的可行组成部分(戒烟线,NRT,戒烟),从而促进未来的传播。与NCI Quitline和许多州服务不同,MBI遵循最佳实践指南,这样做不会增加诊所负担。它还可以改善服务不足的高风险人群获得和参与循证治疗的机会。该项目具有很高的影响潜力:它将导致一个新的,有效的多层次模型,以解决儿童SHSe的重大问题。
次要目标的结果将通过确定模型如何以及为谁工作来为科学和理论提供信息。未来的拆解研究可以评估干预成分的正交和协同效应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRADLEY N COLLINS其他文献
BRADLEY N COLLINS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRADLEY N COLLINS', 18)}}的其他基金
Multilevel tobacco intervention in community clinics for underserved families
在社区诊所为服务不足的家庭进行多层次烟草干预
- 批准号:
9268428 - 财政年份:2015
- 资助金额:
$ 56.01万 - 项目类别:
Pediatrician Advice, Family Counseling, & SHS Reduction for Underserved Children
儿科医生建议、家庭咨询、
- 批准号:
8433536 - 财政年份:2012
- 资助金额:
$ 56.01万 - 项目类别:
Pediatrician Advice, Family Counseling, & SHS Reduction for Underserved Children
儿科医生建议、家庭咨询、
- 批准号:
8237312 - 财政年份:2012
- 资助金额:
$ 56.01万 - 项目类别:
Pediatrician Advice, Family Counseling, & SHS Reduction for Underserved Children
儿科医生建议、家庭咨询、
- 批准号:
8616047 - 财政年份:2012
- 资助金额:
$ 56.01万 - 项目类别:
SHS Treatment for Postpartum African American Smokers
针对产后非裔美国吸烟者的二手烟治疗
- 批准号:
7409018 - 财政年份:2004
- 资助金额:
$ 56.01万 - 项目类别:
SHS Treatment for Postpartum African American Smokers
针对产后非裔美国吸烟者的二手烟治疗
- 批准号:
7124360 - 财政年份:2004
- 资助金额:
$ 56.01万 - 项目类别:
SHS Treatment for Postpartum African American Smokers
针对产后非裔美国吸烟者的二手烟治疗
- 批准号:
6923733 - 财政年份:2004
- 资助金额:
$ 56.01万 - 项目类别:
SHS Treatment for Postpartum African American Smokers
针对产后非裔美国吸烟者的二手烟治疗
- 批准号:
7266361 - 财政年份:2004
- 资助金额:
$ 56.01万 - 项目类别:
SHS Treatment for Postpartum African American Smokers
针对产后非裔美国吸烟者的二手烟治疗
- 批准号:
6822787 - 财政年份:2004
- 资助金额:
$ 56.01万 - 项目类别:
Postpartum Smoking and Infant ETS Reduction Trial
产后吸烟和婴儿 ETS 减少试验
- 批准号:
6620718 - 财政年份:2002
- 资助金额:
$ 56.01万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 56.01万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 56.01万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 56.01万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 56.01万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 56.01万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 56.01万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 56.01万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 56.01万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 56.01万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 56.01万 - 项目类别:
Research Grant














{{item.name}}会员




